학술논문
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
Document Type
Article
Author
Source
In: British Journal of Cancer . (British Journal of Cancer, 31 January 2024, 130(1):53-62)
Subject
Language
English
ISSN
15321827
00070920
00070920